Banana Muffin, brand Surtidoras Bakery, net wt. 1.74 lbs., packaged in rigid plastic clam shell container. No UPC. The allergens decla...
⚠ Critical Alert — Stop Using Immediately
This product has been flagged with severe risks (undeclared allergen). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1283-2019.
The ingredients statement declared wheat, soybean oil, eggs, soy flour, soybean oil, and WHEY. The ingredients statement does not declare Milk as a source of whey and the Contains statement does not declare Milk.
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1283-2019.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact Surtidoras Bakery Inc or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1283-2019.
Surtidoras Bakery Inc
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
Surtidoras Bakery Inc Recall FAQ
Surtidoras Bakery Inc is the subject of a food safety report: Banana Muffin, brand Surtidoras Bakery, net wt. 1.74 lbs., packaged in rigid plastic clam shell container. No UPC. The allergens decla.... The notice was published on March 2, 2019 by the U.S. Food and Drug Administration (FDA). Approximately 104 units are potentially affected.